RdRp mutations are associated with SARS-CoV-2 genome evolution.

COVID-19 Mutation rate RNA-dependent RNA polymerase RdRp SARS-CoV-2

Journal

PeerJ
ISSN: 2167-8359
Titre abrégé: PeerJ
Pays: United States
ID NLM: 101603425

Informations de publication

Date de publication:
2020
Historique:
received: 20 05 2020
accepted: 01 07 2020
entrez: 4 8 2020
pubmed: 4 8 2020
medline: 4 8 2020
Statut: epublish

Résumé

COVID-19, caused by the novel SARS-CoV-2 virus, started in China in late 2019, and soon became a global pandemic. With the help of thousands of viral genome sequences that have been accumulating, it has become possible to track the evolution of the viral genome over time as it spread across the world. An important question that still needs to be answered is whether any of the common mutations affect the viral properties, and therefore the disease characteristics. Therefore, we sought to understand the effects of mutations in RNA-dependent RNA polymerase (RdRp), particularly the common 14408C>T mutation, on mutation rate and viral spread. By focusing on mutations in the slowly evolving M or E genes, we aimed to minimize the effects of selective pressure. Our results indicate that 14408C>T mutation increases the mutation rate, while the third-most common RdRp mutation, 15324C>T, has the opposite effect. It is possible that 14408C>T mutation may have contributed to the dominance of its co-mutations in Europe and elsewhere.

Identifiants

pubmed: 32742818
doi: 10.7717/peerj.9587
pii: 9587
pmc: PMC7380272
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e9587

Informations de copyright

© 2020 Eskier et al.

Déclaration de conflit d'intérêts

Aslı Suner and Gökhan Karakülah are Academic Editors for PeerJ.

Références

Viruses. 2020 Apr 30;12(5):
pubmed: 32366025
Euro Surveill. 2020 Jan;25(4):
pubmed: 32019669
Radiography (Lond). 2020 Aug;26(3):274
pubmed: 32387085
Proc Natl Acad Sci U S A. 2014 Sep 16;111(37):E3900-9
pubmed: 25197083
J Transl Med. 2020 Apr 22;18(1):179
pubmed: 32321524
Genomics. 2020 Sep;112(5):3588-3596
pubmed: 32353474
Emerg Microbes Infect. 2020 Dec;9(1):382-385
pubmed: 32065055
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
Cell. 2020 Apr 16;181(2):223-227
pubmed: 32220310
Curr Neuropharmacol. 2020 May 06;:
pubmed: 32379592
Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):9436-41
pubmed: 26159422

Auteurs

Doğa Eskier (D)

Izmir Biomedicine and Genome Center (IBG), Izmir, Turkey.
Izmir International Biomedicine and Genome Institute, Dokuz Eylül University, Izmir, Turkey.

Gökhan Karakülah (G)

Izmir Biomedicine and Genome Center (IBG), Izmir, Turkey.
Izmir International Biomedicine and Genome Institute, Dokuz Eylül University, Izmir, Turkey.

Aslı Suner (A)

Department of Biostatistics and Medical Informatics, Faculty of Medicine, Ege University, Izmir, Turkey.

Yavuz Oktay (Y)

Izmir Biomedicine and Genome Center (IBG), Izmir, Turkey.
Izmir International Biomedicine and Genome Institute, Dokuz Eylül University, Izmir, Turkey.
Faculty of Medicine, Department of Medical Biology, Dokuz Eylül University, Izmir, Turkey.

Classifications MeSH